Table 3.
Study No. | Pathway | Sites? | Patient set-up | Image acquisitions | Image registrations | Contouring tumour | Contouring organs at risk | Decision to replan/recontour | Plan creation | Plan checking | Decision to treat with adapted plan | On-call provision |
---|---|---|---|---|---|---|---|---|---|---|---|---|
FG1 | Radiographer-led ATS | All standard sites | R | R | R | R | R | R | R | R | R | R, P, C |
Radiographer-led ATS with clinician present #1 | Complex cases – discussed in meeting prior to treatment | R | R | R | R | R | R + C | R | R | C | R, P | |
FG3 | Clinician-light ATP | Prostate | R | R | R | N/A | N/A | P | P | P | R | C |
FG4 | Clinician-light ATP | Prostate | R | R | R | N/A | N/A | P | P | P | R | C |
FG5 | MDT-led ATS | All standard sites | R | R | R | C | C | C | P | P | R + C | N/A |
II6 | MDT-led ATS | All standard sites | R | R | R | C | C | C | P | P | R + C | N/A |
R: Radiographer. P: Physicist. C: Clinician.
Note: FG 2 excluded as not yet treating or finalised workflow and pathway (FG: Focus group. II: Individual interview. ATP: Adapt to position. ATS: Adapt to shape).